Immutep Ltd Files Routine 6-K Disclosure
Ticker: PRRUF · Form: 6-K · Filed: Oct 21, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, routine-disclosure, foreign-private-issuer
TL;DR
IMMUTEP files routine 6-K, no major news.
AI Summary
Immutep Ltd filed a Form 6-K on October 21, 2025, reporting as a foreign private issuer. The company, previously known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the pharmaceutical preparations sector. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing indicates Immutep Ltd is meeting its ongoing reporting obligations as a foreign private issuer with the SEC, which is standard practice for companies with securities traded in the US.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new material information or financial changes disclosed.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- October 20, 2025 (date) — Date of report
- October 21, 2025 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have distributed or are required to distribute to their security holders.
When was Immutep Ltd previously known as?
Immutep Ltd was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
What is Immutep Ltd's primary business sector?
Immutep Ltd operates in the Pharmaceutical Preparations sector, with Standard Industrial Classification code 2834.
Where is Immutep Ltd's principal executive office located?
Immutep Ltd's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does Immutep Ltd file annual reports under Form 20-F or 40-F?
Immutep Ltd indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 267 words · 1 min read · ~1 pages · Grade level 17.6 · Accepted 2025-10-20 20:00:48
Filing Documents
- d62294d6k.htm (6-K) — 10KB
- d62294dex991.htm (EX-99.1) — 15KB
- g62294g1020165050929.jpg (GRAPHIC) — 3KB
- g62294g1020165051023.jpg (GRAPHIC) — 1KB
- 0001193125-25-243950.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 20, 2025 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer